BNP/CALL/BAXTER INTERNATIONAL/50/0.1/20.12.24 Share Price

Warrant

DE000PE892K7

Delayed Deutsche Boerse AG 11:51:07 27/06/2024 am IST
0.013 EUR 0.00% Intraday chart for BNP/CALL/BAXTER INTERNATIONAL/50/0.1/20.12.24
Current month-27.78%
1 month-31.58%
Date Price Change
27/24/27 0.013 0.00%
26/24/26 0.013 0.00%
25/24/25 0.013 -13.33%
24/24/24 0.015 -16.67%
21/24/21 0.018 -5.26%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 11:51 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BAXTER INTERNATIONAL INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE892K
ISINDE000PE892K7
Date issued 16/02/2023
Strike 50 $
Maturity 20/12/2024 (177 Days)
Parity 10 : 1
Emission price 0.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.73
Lowest since issue 0.009

Company Profile

Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.
Sector
-
More about the company

Ratings for Baxter International Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Baxter International Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
33.9 USD
Average target price
45.44 USD
Spread / Average Target
+34.03%
Consensus